Fox Chase Cancer Center News

New GIST Studies Look to Overcome TKI Resistance

Fox Chase Researchers Continue Commitment to Rare GIST Tumors

Several enrolling clinical trials are exploring avenues to overcoming TKI resistance.

The management of gastrointestinal stromal tumors (GIST) was revolutionized with the introduction of tyrosine kinase

VIEW STORY